DK621187A - PHARMACEUTICAL BASIS OF 3,4-DIPHENYLPIPERIDE INGREDIENTS AND THE USE OF IT, AND SUBSTITUTED 3,4-DIPHENYLPIPERIDE INGREDIATES, AND THE PREPARATION OF THESE - Google Patents

PHARMACEUTICAL BASIS OF 3,4-DIPHENYLPIPERIDE INGREDIENTS AND THE USE OF IT, AND SUBSTITUTED 3,4-DIPHENYLPIPERIDE INGREDIATES, AND THE PREPARATION OF THESE

Info

Publication number
DK621187A
DK621187A DK621187A DK621187A DK621187A DK 621187 A DK621187 A DK 621187A DK 621187 A DK621187 A DK 621187A DK 621187 A DK621187 A DK 621187A DK 621187 A DK621187 A DK 621187A
Authority
DK
Denmark
Prior art keywords
diphenylpiperide
ingrediates
ingredients
substituted
preparation
Prior art date
Application number
DK621187A
Other languages
Danish (da)
Other versions
DK621187D0 (en
Inventor
Serge Petit
Jean-Pierre Nallet
Jacques Dreux
Jacqueline Winicki
Original Assignee
Hoechst Sa Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Sa Lab filed Critical Hoechst Sa Lab
Publication of DK621187D0 publication Critical patent/DK621187D0/en
Publication of DK621187A publication Critical patent/DK621187A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK621187A 1986-11-27 1987-11-26 PHARMACEUTICAL BASIS OF 3,4-DIPHENYLPIPERIDE INGREDIENTS AND THE USE OF IT, AND SUBSTITUTED 3,4-DIPHENYLPIPERIDE INGREDIATES, AND THE PREPARATION OF THESE DK621187A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863640475 DE3640475A1 (en) 1986-11-27 1986-11-27 MEDICINAL PRODUCTS BASED ON DERIVATIVES OF 3,4-DIPHENYLPIPERIDINE, THE USE OF THE DERIVATIVES AS A MEDICINAL PRODUCT AND NEW 3,4-DIPHENYLPIPERIDINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF

Publications (2)

Publication Number Publication Date
DK621187D0 DK621187D0 (en) 1987-11-26
DK621187A true DK621187A (en) 1988-05-28

Family

ID=6314857

Family Applications (1)

Application Number Title Priority Date Filing Date
DK621187A DK621187A (en) 1986-11-27 1987-11-26 PHARMACEUTICAL BASIS OF 3,4-DIPHENYLPIPERIDE INGREDIENTS AND THE USE OF IT, AND SUBSTITUTED 3,4-DIPHENYLPIPERIDE INGREDIATES, AND THE PREPARATION OF THESE

Country Status (9)

Country Link
EP (1) EP0273199A3 (en)
JP (1) JPS63141965A (en)
KR (1) KR880006194A (en)
AU (1) AU8182187A (en)
DE (1) DE3640475A1 (en)
DK (1) DK621187A (en)
IE (1) IE873212L (en)
PT (1) PT86211B (en)
ZA (1) ZA878881B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6376672B1 (en) 1999-04-27 2002-04-23 Hoffmann-La Roche Inc. Naphthalenylmethoxypiperidines as renin inhibitors
MXPA04004772A (en) * 2001-11-19 2005-06-06 Elan Pharm Inc (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease.
ATE406894T1 (en) 2003-04-04 2008-09-15 Lundbeck & Co As H 4-(2-PHENYLSULFANYL-PHENYL)-PIPERIDINE DERIVATIVES AS SEROTONIN REUPPOST INHIBITORS
RS50589B (en) 2003-12-23 2010-05-07 H. Lundbeck A/S. 2-(1h-indolylsulfanyl)-benzyl amine comme ssri
AR052308A1 (en) 2004-07-16 2007-03-14 Lundbeck & Co As H DERIVATIVES OF 2- (1H-INDOLILSULFANIL) -ARILAMINE AND A PHARMACEUTICAL COMPOSITION CONTAINING THE COMPOUND
US7629473B2 (en) 2005-06-17 2009-12-08 H. Lundbeck A/S 2-(1H-indolylsulfanyl)-aryl amine derivatives
AR054393A1 (en) 2005-06-17 2007-06-20 Lundbeck & Co As H DERIVATIVES OF BENZO (B) FURANO AND BENZO (B) THIOPHEN, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF DISEASES MEDIATED BY THE INHIBITION OF THE REINFORCEMENT OF AMINA BOSS NEUTRANTS.

Also Published As

Publication number Publication date
DE3640475A1 (en) 1988-06-09
AU8182187A (en) 1988-06-02
ZA878881B (en) 1988-10-26
PT86211A (en) 1987-12-01
DK621187D0 (en) 1987-11-26
EP0273199A2 (en) 1988-07-06
KR880006194A (en) 1988-07-22
IE873212L (en) 1988-05-27
JPS63141965A (en) 1988-06-14
PT86211B (en) 1990-11-07
EP0273199A3 (en) 1988-07-20

Similar Documents

Publication Publication Date Title
DK518987A (en) BENZOYLURINE INGREDIENTS, PROCEDURE FOR THE PREPARATION OF THE SAME AND PESTICIDE CONTAINING THESE
NO166372C (en) PROCEDURE FOR THE PREPARATION OF POLYURINE INGREDIENTS AND / OR POLYURETICS / POLYURETHANE POLYMERS.
ES513431A0 (en) "PROCEDURE FOR THE PREPARATION OF 1,2-A PIRIDINES AND PIRAZINES".
DK343388D0 (en) 2,2-DIMETHYLCHROMAN-3-OL DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF, PHARMACEUTICAL AGENTS CONTAINING THE DERIVATIVES AND THEIR USE FOR THE PREPARATION OF PHARMACEUTICAL AGENTS
DK180389A (en) PROCEDURE FOR DISINFECTION OF LOCATIONS AND APPLICATIONS FOR EXERCISING THE PROCEDURE
IT8522668A0 (en) PROCEDURE FOR THE PREPARATION OF HALOGENATED (2,2)-PARACYCLOPHANS AND MIXTURES OF HALOGENATED (2,2)-PARACYCLOPHANS OBTAINED.
DK158505C (en) PROCEDURE FOR THE PREPARATION OF CHEESE DESULATOR, AND USE OF THE PRODUCT,
DK284585D0 (en) 1,4-DIHYDROPYRINE INGREDIENTS, PROCEDURES FOR THE PREPARATION OF SUCH COMPOUNDS, AND MEDICINAL CONTAINING THESE
NO167751C (en) TWO COMPONENTS HARDENABLE PREPARATION AND USE OF IT.
DK419287A (en) PROCEDURE FOR THE PREPARATION AND USE OF SOLID, PHYTOACTIVE AGENTS
DK439589D0 (en) FLUOR-SUBSTITUTED 4'-DEMETHYLEPIPODOPHYLLOTOX INGREDIENTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME
DK621187A (en) PHARMACEUTICAL BASIS OF 3,4-DIPHENYLPIPERIDE INGREDIENTS AND THE USE OF IT, AND SUBSTITUTED 3,4-DIPHENYLPIPERIDE INGREDIATES, AND THE PREPARATION OF THESE
NO895031D0 (en) 2-IMINO-6-POLYFLUORAL COCOYBENZOTIAZOL AND PREPARATION thereof.
IT8821300A0 (en) PROCEDURE FOR THE PREPARATION OF MORNIFLUMATO AND SIMILARES.
DK100289A (en) PROCEDURE FOR THE PREPARATION OF N-SULPHONYLURIC INGREDIENTS
DK164785C (en) 5-ARYL-2,4-DIALKYL-3H-1,2,4-TRIAZOL-3-THIONES, THEIR PREPARATION AND THEIR USE FOR THE PREPARATION OF ANTIPEDRESSIVE AGENTS
NO903347D0 (en) PROCEDURE FOR THE PREPARATION OF 14,17ALFA-ETHANO AND ETHANOESTRATRIAGES.
NO905543L (en) PROCEDURE FOR THE PREPARATION AND USE OF AMINOPYRIDINYLMETHANOLS AND AMINOMETHYLPYRIDINAMINES.
FI860525A0 (en) NY JORDBRUKSKEMIKALIE MED NAMNET 'SUBSTANCE NO.51262'.
ATE80872T1 (en) HERBICIDES OXOINDANS AND TETRAHYDRONAPHTHALINES.
DK511687D0 (en) PHARMACEUTICAL PREPARATIONS, AND THE PREPARATION AND USE OF THEM
NO872646L (en) CYTORHODIN S-DERIVATIVES AND PROCEDURE FOR THE PREPARATION OF THESE.
DK585288A (en) HERBICIDE SULPHONYLURINE INGREDIENTS
DK328087A (en) N-IMIDAZOLYLMETHYL-DIPHENYLAZOMETHINES AND PROCEDURES FOR THE PREPARATION OF SUCH COMPOUNDS AND USE OF THESE IN PHARMACEUTICAL PREPARATIONS
DK131687D0 (en) N-SUBSTITUTED AMINOALCANIC ACIDS, PROCEDURES FOR THEIR PREPARATION, THEIR USE, AND PHARMACEUTICAL PREPARATIONS ON THE BASIS OF THESE COMPOUNDS

Legal Events

Date Code Title Description
ATS Application withdrawn